ALL >> General >> View Article
Cordenpharma Invests $900m In Usa & Europe Peptide Expansion
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technology platform. These transformational plans consist of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions designed and built according to the pharmaceutical industry's most stringent quality and technical standards for short and long peptide manufacturing, including Biologics License Applications (BLA) requirements.
The US expansion involves bringing additional Peptide capacity to the CordenPharma Colorado site with the planned construction of a new large-scale manufacturing facility, and an additional increase in manufacturing trains in the existing facility. This is the result of rapidly increasing demand in the Diabetes and Obesity Glucagon-like Peptide 1 (GLP-1) agonist medications market, and comes off the back of multiple, long-term, multiyear contracts totaling ~€3bn, with potential upsides.
The European expansion centers on the construction of a new state-of-the-art greenfield ...
... facility, with the aim of creating additional Peptide capacity to serve customers from initial early clinical to late-stage commercial manufacturing. The new site will be located in the heart of Europe, fully-integrated within CordenPharma's existing facility network.
In 2022, CordenPharma was acquired by Astorg, a leading Pan-European private equity firm, and its ambitious growth plans aim to help the company reach their ~€1bn sales mark for its pioneering Peptide Platform, and ~€1.8bn total group revenue by 2028. Upon completion, the new constructions will be fully integrated within its outstanding network of world-class cGMP manufacturing facilities, along with the dedicated technical and regulatory support by expert teams needed to secure innovators' supply chains with small to large-scale fully-integrated services from APIs to Drug Products.
More Information : https://www.techdogs.com/tech-news/pr-newswire/cordenpharma-invests-900m-in-transformational-peptide-platform-expansion-in-the-usa-europe
Add Comment
General Articles
1. Sarm1 Inhibitor: A Potential New Therapy For Nerve Injury And Neurodegenerative DiseasesAuthor: colin
2. Extract Supermarket Data From Woolworths And Coles: Key Benefits
Author: iwebdatascraping
3. How To Find Reliable Telecommunication Service Providers Near You
Author: sehar
4. فوائد اشتراك جيم باص
Author: sara ashraf
5. Leveraging Global Networks: How Doctors Can Benefit From A Digital Community
Author: Mihir
6. أنواع العاب اكس بوكس
Author: sara ashraf
7. United Kingdom Gas Leak Detector : The Importance Of Gas Leak Detection In The United Kingdom
Author: colin
8. How To Protect Your Eyes From Digital Eye Strain
Author: Itone Eye Drops
9. Buying A Cat In Koramangala: A Guide To Buying From Mykitten
Author: MyKitten - Ranjeet
10. Affordable Driveway Companies Near Me
Author: State Asphalt Paving & Sealing LLC
11. Rare Kidney Disease: An Overview
Author: colin
12. Must Know 10 Tips For Hiring The Best Furniture Design Service
Author: Shalin Designs
13. What Do Nazi Germany And Modern Russia Have In Common?
Author: Martin Koppar
14. Hoist Your Way Of Life With Skyhigh Towers In Hinjewadi, Pune
Author: Tarun
15. X96 Max Plus Android 9.0 Tv Box With 4gb Ram 64gb Rom
Author: Raxxio